Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Acknowledgements to Reviewers:
Volume: 15 Issue: 2
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers:, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2015; 15 (2) . https://dx.doi.org/10.2174/187152221502151013172046
DOI https://dx.doi.org/10.2174/187152221502151013172046 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
20
Related Articles
-
Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Current Diabetes Reviews Pharmacological Characteristics of Parenteral IGF-I Administration
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Drug Delivery & Formulation Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity
Current Pharmaceutical Design The Concept of Depression as a Dysfunction of the Immune System
Current Immunology Reviews (Discontinued) Food Intake and Nutritional Status of Children With High Levels of Arsenic in Hair: Cases Study of a Historical Cohort
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
Current Pharmaceutical Design Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease
Current Drug Targets Recent Advances in the Chemistry of Phthalimide Analogues and their Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Intestinal Microbiota: A Regulator of Intestinal Inflammation and Cardiac Ischemia?
Current Drug Targets Association of Cytokine Gene Polymorphisms (IL6, IL10, TNF-α, TGF-β and IFN-γ) and Graves’ Disease in Turkish Population
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting STAT1 in Both Cancer and Insulin Resistance Diseases
Current Protein & Peptide Science Emergence of Lipid-Based Vesicular Carriers as Nanoscale Pharmacotherapy in Rheumatoid Arthritis
Recent Patents on Nanomedicine Current and Emerging Strategies in Osteoporosis Management
Current Pharmaceutical Design The Antioxidant Properties of Organosulfur Compounds (Sulforaphane)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Clarithromycin Attenuates Left Ventricular Remodeling and Dysfunction after Pressure Overload in Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Targeting Plasminogen Activator Inhibitor-1: Role in Cell Signaling and the Biology of Domain-Specific Knock-in Mice
Current Drug Targets Introduction: P2 Receptors
Current Topics in Medicinal Chemistry